13 filings
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
16 Dec 19
Amneal Appoints Jeff George, John Kiely and Shlomo Yanai to Board of Directors
4:50pm
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
10 Dec 19
Amneal to Acquire Majority Interest in AvKARE, Enhancing Access
4:51pm
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
6 Nov 19
Amneal Reports Third Quarter 2019 Financial Results
6:54am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
11 Oct 19
Submission of Matters to a Vote of Security Holders
12:07pm
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
5 Aug 19
Amneal Reports Second Quarter 2019 Financial Results
6:20am
8-K
6kc2vbi
5 Aug 19
Paul Meister Elected Chairman of the Board
6:13am
8-K
pw5hr5yh4z3b4567cza
10 Jul 19
Amneal Pharmaceuticals Announces Restructuring and Costs Savings Plan to Improve Operations and Position the Company for Future Growth
4:52pm
8-K
ouw3g
9 May 19
Departure of Directors or Certain Officers
4:43pm
8-K
vk55xv g2xvm3oow
9 May 19
Amneal Reports First Quarter 2019 Financial Results
6:42am
8-K
p3i r6wlupixf
28 Feb 19
Amneal Reports Fourth Quarter and Full Year 2018 Financial Results
8:02am
8-K
045a7o m5b
24 Jan 19
Departure of Directors or Certain Officers
4:25pm
8-K
sf1y908497u
8 Jan 19
Regulation FD Disclosure
9:14am
8-K
c6gj3mp50syu7sc 9t
7 Jan 19
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer and Corporate Secretary
4:23pm
- Prev
- 1
- Next